Executive Summary
This procedural order from the Düsseldorf Local Division addressed a request by Valeo Electrification to lift an existing confidentiality order concerning EP 3 320 602 B1. The Court upheld the protection of confidential information, classifying specific documents submitted by the Defendants (Magna entities) as trade secrets under Article 58 UPCA. Consequently, the Applicant's request to remove these restrictions was dismissed, reinforcing the importance of maintaining confidentiality in UPC proceedings.
What the Court Held — Ratio Decidendi
The Court classified specific information submitted by the Defendants as confidential under Article 58 UPCA and R. 262A RoP, thereby restricting access to the unredacted version of the Objection. The court found that the Applicant failed to sufficiently demonstrate that the claimed confidential information was publicly discussed in prior proceedings.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Düsseldorf (DE) Local Division. Understanding the court's reasoning in Valeo Electrification vs Magna International France, SARL; Magna PT B.V. & Co. KG; Magna PT s.r.o. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Dyson Technology LimitedvsDreame International (Hongkong) Limited, Teqphone GmbH, Eurep GmbH, Dreame Technology AB
Dyson Technology Limited successfully sought provisional measures against the Dreame group and its affiliates in a UPC action concerning hair styling appliances. The ruling was significant for establishing jurisdiction over international companies operating through EU Authorized Representatives, confirming that these representatives can act as 'anchor defendants' under Brussels I rules. This decision provides clarity on how IP rights holders can enforce their patents against global supply chains anchored by local intermediaries. The case underscores the practical application of cross-border legal principles within the UPC framework, particularly regarding product safety regulations and distribution networks.
Hanshow Technology Co. LtdvsVusionGroup SA (vormals SES-imagotag SA)
This UPC Appeals Board decision clarifies the procedural rules governing cost determination in complex litigation. The court ruled that even when a party seeks to recover costs related to the appeals process itself, the application must ultimately be filed with and decided by the Court of First Instance. This ruling reinforces the structured nature of the UPC's procedure, ensuring that all final cost determinations follow the established framework (R. 150 ff. VerfO). Practitioners should note this when planning their costs recovery strategy in multi-stage UPC proceedings.
Network System Technologies LLC.vsVolkswagen AG
In a procedural matter concerning an appeal, the UPC Court of Appeal rejected Volkswagen AG's request to expedite the proceedings and shorten deadlines. Volkswagen argued that delays were causing increased legal costs related to security for costs. The court ruled that the request lacked sufficient substantiation and specificity, emphasizing adherence to established procedural timelines and principles of proportionality.
Abbott Diabetes Care Inc.vsDexcom Inc.
This procedural order addressed Abbott Diabetes Care Inc.'s request for the UPC to compel Dexcom entities to disclose the entire distribution chain of their G6 and G7 diabetes monitoring systems. The Court ruled that while such information can be requested during proceedings, Abbott's specific demand was disproportionate. The judge found that because Abbott had targeted only certain distributors, requesting the full global supply chain was not reasonably necessary for advancing its case.
Meril Italy SrlvsEdwards Lifesciences Corporation
In a complex revocation action, the UPC Central Division rejected Meril Italy Srl's attempt to invalidate EP 3 646 825. The patent relates to an advanced prosthetic heart valve with a unique hexagonal cell frame design. Despite multiple procedural maneuvers and consolidation of related counterclaims, the Court upheld the patent's validity after incorporating amendments. This case underscores the UPC's jurisdiction over complex medical device patents and its strict approach to maintaining patent rights unless clear invalidity grounds are established.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.